Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001957554-26-000003

Chief Financial Officer gave up 26,645 shares (to pay taxes)

  • Chief Financial Officer acquired 94,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Balthaser Kevin · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-31 Exercise or conversion : show line 1 in the form +73,750 166,358 D
2025-12-31 Shares withheld for taxes : show line 2 in the form −19,934 $3.01 $60,001 146,424 D
2026-01-01 Exercise or conversion : show line 3 in the form +7,500 153,924 D
2026-01-01 Shares withheld for taxes : show line 4 in the form −2,250 $3.01 $6,773 151,674 D
2026-01-02 Exercise or conversion : show line 5 in the form +13,200 164,874 D
2026-01-02 Shares withheld for taxes : show line 6 in the form −4,461 $2.88 $12,848 160,413 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-31 Exercise or conversion : show line 7 in the form Restricted Stock Units −73,750 0 D
2026-01-01 Exercise or conversion : show line 8 in the form Restricted Stock Units −7,500 7,500 D
2026-01-02 Exercise or conversion : show line 9 in the form Restricted Stock Units −13,200 13,600 D
Loading xslF345X05/form4-01052026_090132.xml…